US Oncology Clinical Development

US Oncology Clinical Development is a full-service contract research organization (CRO) with a site feasibility approach that offers full-service clinical trial monitoring services to pharmaceutical and biotechnology companies. Our CRO can manage all tasks necessary to get a product approved by the FDA, including recruiting subjects, identifying sites, monitoring study data, conducting site audits and training, collecting and analyzing data, and submitting documents and reports to regulatory authorities.   With our unique site relationships, full feasibility data is part of every trial at no cost to our clients. US Oncology Clinical Development prides itself on this simple fact: Given our leadership and expertise with oncology trials, our unique feasibility approach and our staff’s level of experience, it is a smart choice to do business with US Oncology Clinical Development. .    Our unique focus on oncology means we bring particular expertise to this growing area of investigation. We have over 200 participating research sites and access to more than half a million patients a year.   US Oncology Clinical Development is a full-service CRO with expertise in the following areas of oncology clinical trials:    Phase I: In-Patient & Out-Patient, including first time in man Phase II-IV Data Management Biostatistics Medical Writing Oncology Medical Monitoring Protocol Development Regulatory Submissions Monitoring & Auditing Project Management Site Selection True Feasibility Data See below who to contact to discuss how US Oncology Clinical Development can help you.    For all inquiries involving broader research programs, alliances, partnerships, or other business development opportunities: Scott Bazemore Director of Clinical Research Development & Personalized Science (281) 863-4678 ph (832) 601-6644 fax (281) 787-6325 cell Toll Free: (800) 381-2637 ext. 4678 Scott.Bazemore@usoncology.com        For TOP & Phase I trials in all tumor types: William D. Fox, MPH Associate Director, Early Phase Development & Personalized Medicine Translational Oncology Program / Phase I (281) 863-6688 ph (832) 348-5731 fax (832) 317-9946 cell Toll Free: (800) 381-2637 ext. 6688 William.Fox@usoncology.com    For Phase II-IV trials in the Lung, GI, Hematology, and Lung areas: Noelle Gaskill Manager of Clinical Research Development GI, Heme and Lung Programs (281) 863-6675 ph Noelle.Gaskill@usoncology.com    For Phase II-IV trials in the Breast, DTC, GYN, and GU areas: Michelle Calabretta, Ph.D. Manager, Clinical Trial Development Breast, GYN, GU Programs (281) 863-6516 ph (832) 348-5398 fax Toll Free: (800) 381-2637 ext. 6516 Michelle.Calabretta@usoncology.com